// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

18,789
Stories Indexed
Live
Feed Status
6
Data Sources
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
ALL STORIES · 18,789 results Live
Offering SRNAI Jun 17 — 0.00

SharonAI Holdings Inc. enters securities purchase agreement for private placement offering

SharonAI Holdings Inc. entered into a Securities Purchase Agreement dated June 17, 2026 to issue and sell securities to multiple purchasers under SEC Rule 506 exemption. The transa…

M&A TWAV Jun 17 ▲ +0.65

TaoWeave invests $1M in Manako Labs, becomes North American commercialization partner

TaoWeave shifted from being a Bittensor ecosystem investor to building operating businesses within it, investing $1 million in UK-based AI company Manako Labs and securing a multi-…

M&A HLIT Jun 17 ▲ +0.75

Harmonic completes $145M sale of Video Business to MediaKind

Harmonic Inc. completed the divestiture of its Video Business to MediaKind for $145 million in cash, transforming itself into a pure-play broadband company. The transaction strengt…

Earnings PGR Jun 17 ▲ +0.85

Progressive reports 36% increase in May net income to $1.445B

Progressive Corporation reported May 2026 results with net income of $1.445 billion, up 36% year-over-year, driven by 10% growth in net premiums earned and an improved combined rat…

Other AMAZE Jun 17 ▲ +0.50

Amaze Holdings establishes 2026 Equity Incentive Plan for employee retention.

Amaze Holdings adopted a new equity incentive plan effective April 28, 2026, subject to shareholder approval, offering various award types including stock options and restricted aw…

Regulatory VSTM Jun 17 ▲ +0.75

Verastem reports 86% 6-month OS rate in RAMP 205 pancreatic cancer trial

Verastem Oncology announced positive updated results from RAMP 205 evaluating avutometinib plus defactinib combined with standard chemotherapy in first-line metastatic pancreatic c…

M&A ANIP Jun 17 ▲ +0.50

AstroNova to be acquired by Orion Merger Parent in all-stock transaction

AstroNova Inc. has entered into a merger agreement with Orion Merger Parent, Inc. and Orion MergerCo X, Inc., dated June 16, 2026. The transaction represents a significant corporat…

Other OBND Jun 17 — 0.00

Our Bond, Inc. files 8-K exhibit with limited disclosure details

Our Bond, Inc. submitted an 8-K filing with Exhibit 99.1 but provided minimal substantive information. Without specific financial or operational details, market impact cannot be de…

Regulatory PLBY Jun 17 — +0.10

Playboy increases equity plan share limit to 14.3M with annual 4% adjustments

Playboy amended its 2021 Equity and Incentive Compensation Plan, raising the overall share limit to 14,262,364 shares with automatic annual increases of up to 4% through 2031. The …

Leadership ELWT Jun 17 ▲ +0.70

Elauwit Connection appoints Nick Jones as Chief Information Officer and Chief Operating Officer

Elauwit Connection announced the appointment of Nick Jones as Chief Information Officer and Chief Operating Officer, replacing Rick Alder who led the company through its IPO phase.…

Leadership CME Jun 17 ▲ +0.50

CME Group extends Terrence Duffy as CEO through 2027, then Executive Chairman role

CME Group entered into a transition agreement with Chairman and CEO Terrence Duffy, extending his tenure through December 31, 2027. Duffy will serve as CEO through February 28, 202…

Regulatory SHF4 Jun 17 — 0.00

Shift4 Payments files Second Amended and Restated Certificate of Incorporation

Shift4 Payments adopted an updated certificate of incorporation authorized to issue 320 million shares including 300 million Class A common shares and 20 million preferred shares. …

Restructuring ALLO Jun 17 — 0.00

Allbirds changes corporate name to Smartbird, Inc. via certificate amendment

Allbirds, Inc. amended its certificate of incorporation to change its corporate name to Smartbird, Inc., effective June 15, 2026. The filing also revised the company's business pur…

Offering VZ Jun 17 — 0.00

Verizon completes private exchange offers and consent solicitations for 11 debt series

Verizon announced final results of exchange offers to refinance outstanding notes and received requisite consents for proposed indenture amendments eliminating restrictive covenant…

Other KLNG Jun 17 ▲ +0.75

KOIL Energy Secures Major Subsea Project Using New and Existing Carousels

KOIL Energy Solutions won a major subsea umbilical handling contract requiring deployment of a newly acquired 3,500-metric-ton carousel and an existing fleet asset, with work sched…

M&A BBBY · FTHM Jun 17 ▲ +0.50

Fathom Holdings to merge with Bed Bath & Beyond in stock transaction

Fathom Holdings Inc. has entered into a merger agreement to acquire Bed Bath & Beyond Inc., with Bed Bath & Beyond shareholders to receive Fathom stock. The transaction combines a …

Other RSVR Jun 17 — 0.00

Reservoir Media releases investor presentation for June 2026

Reservoir Media filed an investor presentation as an exhibit to an 8-K filing. The document contains forward-looking statements about future business opportunities, financial perfo…

Restructuring AZTR Jun 17 ▲ +0.65

Azitra pivots strategy toward synthetic biology and AI-driven therapeutics

CEO Francisco Salva outlined strategic reorientation initiatives following a $10.5M financing in March, expanding beyond precision dermatology into cosmetic ingredients and biotech…

Regulatory AVLN Jun 17 ▲ +0.75

Avalyn Pharma completes enrollment of 375 patients in Phase 2b MIST trial

Avalyn Pharma announced completion of target enrollment in its Phase 2b MIST clinical trial evaluating AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis, with topline r…

Regulatory ELTX Jun 17 ▲ +0.75

Elicio Reports Complete Responses in Pancreatic Cancer Patients Receiving ELI-002 7P Plus Checkpoint Inhibition

Elicio Therapeutics reported that three metastatic pancreatic cancer patients achieved confirmed complete responses after receiving ELI-002 7P followed by nivolumab-based therapy, …